Loading...
Loading...
Neurology
Generic: capsaicin 8%
Qutenza serves as a crucial biologic therapy, providing essential relief for individuals battling neuropathic pain associated with postherpetic neuralgia (PHN), a persistent and often debilitating condition arising from nerve damage following a shingles outbreak. As a cornerstone of treatment, Qutenza offers targeted pain management to alleviate discomfort and improve the overall quality of life for those affected by this chronic pain syndrome.
Qutenza, featuring the active ingredient capsaicin, represents an innovative approach to neuropathic pain management by desensitizing pain-sensing nerves and reducing pain transmission signals. By delivering a high-concentration capsaicin patch to the affected area, Qutenza effectively blocks the transmission of pain sensations and provides long-lasting relief from PHN-associated pain.
Administered via topical application, Qutenza ensures efficient and localized delivery of capsaicin to the affected nerve endings, facilitating sustained pain relief and improved functional outcomes for individuals with PHN. With its non-invasive application and extended duration of action, Qutenza offers convenience and efficacy in managing neuropathic pain.
Dosage regimens for Qutenza are tailored to each patient’s individual pain severity and treatment response. Healthcare professionals carefully assess the affected area and apply the Qutenza patch accordingly, optimizing pain relief and minimizing adverse effects.
Prior to Qutenza application, patients undergo thorough assessment and preparation to ensure safe and effective pain management. Healthcare providers educate patients on the application process, potential side effects, and strategies for managing discomfort during and after treatment, empowering them to actively participate in their pain management.
While Qutenza is generally well-tolerated, some individuals may experience side effects. Common side effects may include:
Serious side effects are rare but may include severe skin reactions or allergic reactions. Patients should promptly report any concerning symptoms to their healthcare provider.
Qutenza represents a significant advancement in the management of neuropathic pain associated with PHN, offering targeted relief and improved quality of life for individuals grappling with this chronic pain syndrome. By desensitizing pain-sensing nerves and reducing pain transmission signals, Qutenza enables patients to regain control over their pain and pursue daily activities with greater comfort and confidence.
Ready to prescribe Qutenza? Use our order form finder or contact our clinical intake team directly.
Find Order FormCall 1-800-581-0645We work with Medicare, Medicaid, and all major commercial insurers.
View Accepted Insurances →